Navigation Links
Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
Date:3/3/2008

harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercial
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
9. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
10. Consortium publishes Phase II map of human genetic variation
11. The Lancet Publishes Vasogens ACCLAIM Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... San Diego, CA (PRWEB) July 24, 2014 ... in the reporting of molecular diagnostic test results. ... tracking capabilities necessary for the validation and reporting ... in oncology. Molecular diagnostics is a rapidly growing ... for infectious disease, genetic predisposition, cancer, and companion ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 International research ... announced that its biobanking project, Provia Laboratories , ... its growing Advisory Board. Scott Wolf , CEO ... have Dr. Vaught onboard with Provia’s ever-expanding Advisory Board. ... that Provia’s management team brings to this field, should ...
(Date:7/23/2014)... great strides in saving China,s endangered national treasure, the ... giant panda reserves that have been established and three ... pandas remain in the wild. , Breeding programs ... panda by improving genetic diversity, avoid inbreeding and ultimately, ... these high-profile programs doing so far? , In a ...
(Date:7/23/2014)... the Vienna University of Technology and the Maria ... perfect semiconductor crystals into a silicon nanowire. With ... fast and multi-functional processing units can be accommodated ... research results will be published in the journal ... the cornerstone of future chip technology, but the ...
Breaking Biology Technology:New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4A crystal wedding in the nanocosmos 2
... 1, 2003 at the Midwest Express Center inMilwaukee, Wisconsin, ... of migrating Microsoft Windows NT(R) 4.0 environments to WindowsServer ... connected, scalable,reliable platform that has been designed to meet ... problems. , , ,"We are very pleased to ...
... always, these are general rules, and any good entrepreneur will ... time, in the last 3.5 years weve received about 1,500 ... 100 detailed reviews, and participated in or facilitated more than ... seven rules on avoiding mistakes, and a final reminder of ...
... MADISON - A veteran television reporter recently asked me to ... expect to find jobs after they complete their education. The ... know, I would invest every penny I have in those ... Labor Day passes in Wisconsin, the question about jobs for ...
Cached Biology Technology:"For Angels Only...When to say No... 2"For Angels Only...When to say No... 3Heres how todays Wisconsin children will find jobs tomorrow 2Heres how todays Wisconsin children will find jobs tomorrow 3
(Date:7/24/2014)... An international team of researchers led by the University ... community-led marine conservation in the Western Indian Ocean. ... ONE , point to a revolution in the management ... sites more than 11,000 km in the ... areas (MPAs) are zones of the seas and coasts ...
(Date:7/24/2014)... in German . ... asthma sufferers worldwide, a further 600 million people living ... global population contending with allergic rhinitis (allergic inflammation of ... other organs and parts of the body beyond the ... the form of inflammatory bowel diseases such as colitis ...
(Date:7/24/2014)... is available in German . ... Norway and they are a common sight on the roads ... cars topped the list of new vehicle registrations for the ... in Germany, where electric vehicles claim only a small portion ... roads in Germany, only a mere 8000 are electric powered. ...
Breaking Biology News(10 mins):Western Indian Ocean communities play vital role in conservation 2New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3Nano-supercapacitors for electric cars 2Nano-supercapacitors for electric cars 3
... President George Bush outlined his plan to reduce the nation's ... billion gallons a year of renewable and alternative fuels by ... of 7.5 billion gallons by 2012. , Among the most ... main biofuel used in the United States is ethanol distilled ...
... In his Jan. 23 State of the Union address, President ... on foreign oil by requiring the production of 35 billion ... roughly five times the current target set by Congress of ... alternatives are fuels derived from biological material. Currently, the main ...
... on the amount of salt in their diet could reduce their ... report on bmj.com today. , Researchers in Boston also ... death from cardiovascular disease by up to a fifth. ... to the heart or arteries, for example a stroke or heart ...
Cached Biology News:Custom-made cancer cell attacks 2Custom-made cancer cell attacks 3Cellulosic ethanol: Fuel of the future? 2Cellulosic ethanol: Fuel of the future? 3Eating less salt could prevent cardiovascular disease 2
A camera based compact unit for high speed scanning of 2D barcoded tubes in a cluster rack. This reader has been designed to read both 96 and 48 tube rack configurations and be compatible with common...
... of VARIOMAG Magnetic Stirrers operate without any ... mechanical bearings, making VARIOMAG Magnetic Stirrers 100% ... inductive drive can be hermetically sealed, making ... This is why VARIOMAG Magnetic Stirrers are ...
PTFE/red rubber septum silver aluminum seal ,11 mm seal diam. ...
...
Biology Products: